| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/09/1994 | EP0582318A1 Use of carnosic acid for its anticarcinogenic and antiviral properties |
| 02/09/1994 | EP0582261A1 Cephalosporin compounds and processes for the preparation thereof |
| 02/09/1994 | EP0582243A2 HCV peptide antigens and a method of testing for the hepatitis C virus (HCV) |
| 02/09/1994 | EP0581906A1 ABROGATION OF VIRAL RESISTANCE TO NUCLEOSIDE ANALOGUES BY DOUBLE-STRANDED RNAs |
| 02/09/1994 | EP0581899A1 Improved process for the preparation of 1s-(1r*, 2s*, 3r*)]-n-(4-(morpholinylsulfonyl)-l-phenylalanyl-3-(2-amino-4-thiazolyl)-n- (1-cyclohexylmethyl)-2,3-dihydroxy-5-methylhexyl]-l-alaninamide |
| 02/09/1994 | EP0581856A1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 02/09/1994 | EP0581848A1 Closed sense and antisense oligonucleotides and uses thereof |
| 02/09/1994 | EP0581836A1 Hybrid transposon with a pt-operon, plasmids and bacterial strains therefor |
| 02/09/1994 | CN1081716A Recombiant human hiv-neutralizing monoclonal antibodies for prevention and treatment of hiv infection |
| 02/09/1994 | CA2141030A1 Liponucleotides of seco-nucleosides, their production as well as their use as antiviral pharmaceutical agents |
| 02/08/1994 | US5284963 Reacting 9-amino tetracycline derivative with haloacyl halide in mixture of polar aprotic solvent, inert solvent, base; reacting product under inert atmosphere with nucleophilic amine |
| 02/08/1994 | US5284855 7-(2,7-diazabicyclo[3.3.0]octyl)-3-quinolone-and-naphthyridonecarboxylic acid derivatives |
| 02/08/1994 | US5284849 Renin inhibitors |
| 02/08/1994 | US5284656 Pulmonary administration of granulocyte colony stimulating factor |
| 02/08/1994 | CA2103536A1 Peptides capable of inhibiting the activity of hiv protease, their preparation and their use |
| 02/08/1994 | CA2103533A1 Hcv peptide antigens and method of determining hcv |
| 02/07/1994 | CA2101901A1 Therapeutic heterocyclic derivatives |
| 02/03/1994 | WO1994002637A1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure |
| 02/03/1994 | WO1994002614A1 PEPTIDES THAT MIMIC gp120 HIV EPITOPE |
| 02/03/1994 | WO1994002612A1 Anti-feline immunodeficiency virus (fiv) vaccines |
| 02/03/1994 | WO1994002596A1 Method for preventing zoster or alleviating varicella related post-herpetic neuralgia |
| 02/03/1994 | WO1994002505A1 Compounds which inhibit hiv replication |
| 02/03/1994 | WO1994002501A1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof |
| 02/03/1994 | WO1994002499A1 Oligonucleotide alkylphosphonothioates |
| 02/03/1994 | WO1994002498A1 Hybrid oligonucleotide phosphorothioates |
| 02/03/1994 | WO1994002496A1 Derivatives of 16-membered ring antibiotic macrolides |
| 02/03/1994 | WO1994002489A1 Cephalosporins and 1-carba-1-dethia cephalosporins |
| 02/03/1994 | WO1994002488A1 BIS-STAUROSPORINE AND K-252a DERIVATIVES |
| 02/03/1994 | WO1994002487A1 Novel pyridonecarboxylic acid derivatives and processes for preparing the same |
| 02/03/1994 | WO1994002485A1 Rapamycin derivatives |
| 02/03/1994 | WO1994002480A1 Quinoline and naphthyridine prodrugs |
| 02/03/1994 | WO1994002479A1 Novel diazabicycloalkenes and processes for the preparation thereof |
| 02/03/1994 | WO1994002478A1 (hetero)-aryl ketones derivatives with antibacterial properties |
| 02/03/1994 | WO1994002469A1 Pyrimidine compounds used in the therapy |
| 02/03/1994 | WO1994002448A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | WO1994002447A1 Hydroxamic acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002446A1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 02/03/1994 | WO1994002164A1 Granulocyte colony-stimulating factor solution delivery method |
| 02/03/1994 | WO1994002155A1 Antiviral combinations |
| 02/03/1994 | WO1994002154A1 Antiviral combinations |
| 02/03/1994 | WO1994002146A1 Flavopereirine-based pharmaceutical composition and use thereof for treating hiv |
| 02/03/1994 | WO1994002139A1 Composition and methods for decreasing muscle breakdown |
| 02/03/1994 | WO1994002137A1 Rapamycin derivatives |
| 02/03/1994 | WO1994002136A1 Rapamycin derivatives |
| 02/03/1994 | CA2141214A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds |
| 02/03/1994 | CA2140924A1 Bis-staurosporine and k-252a derivatives |
| 02/03/1994 | CA2140669A1 Pseudo-half-knot rna formation by hybridization of antisense oligonucleotides to target rna's secondary structure |
| 02/03/1994 | CA2140542A1 Oligonucleotide alkylphosphonothioates |
| 02/03/1994 | CA2140453A1 Novel diazabicycloalkenes and processes for the preparation thereof |
| 02/03/1994 | CA2140445A1 Procede d'administration de solutions de facteur de stimulation des colonies granulocytaires |
| 02/03/1994 | CA2140243A1 Derivatives of 16-membered ring antibiotic macrolides |
| 02/03/1994 | CA2140237A1 Antiviral combinations |
| 02/03/1994 | CA2140151A1 Peptides that mimic gp120 hiv epitope |
| 02/03/1994 | CA2140135A1 Quinoline and naphthyridine prodrugs |
| 02/03/1994 | CA2140018A1 Pyrimidine compounds used in the therapy |
| 02/02/1994 | EP0581652A1 Pradimicins T1 and T2 and 11-0-dexylosylpradimicin T1, new members of the pradimicin family of antibiotics |
| 02/02/1994 | EP0581552A2 Triazolylthiomethylthio cephalosporin hyrochloride, its crystalline hydrate and the production of the same |
| 02/02/1994 | EP0581500A1 Antibiotic carbapenem compounds |
| 02/02/1994 | EP0581429A2 Process for synthesizing cyclic depsipeptides |
| 02/02/1994 | EP0580814A1 Antibacterial mild liquid skin cleanser |
| 02/02/1994 | EP0580782A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof. |
| 02/02/1994 | EP0580754A1 Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences |
| 02/02/1994 | EP0580657A1 Use of guanine derivative or a prodrug thereof in the treatment of hiv-1 infection |
| 02/02/1994 | EP0580632A1 Antibiotic carbapenem derivatives |
| 02/02/1994 | EP0580627A1 Pharmaceutical composition for the treatment of gastritis |
| 02/02/1994 | EP0580609A1 Pharmaceutical xanthone derivatives |
| 02/02/1994 | EP0393066B1 Cephalosporin antibiotics |
| 02/02/1994 | EP0290446B1 Vaccines for human respiratory virus |
| 02/02/1994 | CN1081442A Benzodiazepines |
| 02/01/1994 | US5283331 Viricides |
| 02/01/1994 | US5283191 Mareks' disease virus vaccine |
| 02/01/1994 | US5283172 Type-C rotavirus cultures and uses therefor |
| 02/01/1994 | CA2101502A1 Triazolylthiomethylthio cephalosporin hydrochloride, its crystalline hydrate and the production of the same |
| 01/28/1994 | CA2101197A1 Pradimicins t1 and t2 and 11-o-dexylosylpradimicin t1, new members of the pradimicin family of antibiotics |
| 01/26/1994 | EP0580480A1 Pradimic acids, amides, and novel pradimicin derivatives |
| 01/26/1994 | EP0580402A2 Aminediol protease inhibitors |
| 01/26/1994 | EP0580185A1 Medicaments |
| 01/26/1994 | EP0579968A1 4-Iminoquinolines, processes for their preparation and their use |
| 01/26/1994 | EP0579939A1 Phospholipid derivatives |
| 01/26/1994 | EP0579826A1 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics |
| 01/26/1994 | EP0579765A1 Method and composition for the treatment of herpes related disorders |
| 01/26/1994 | EP0579763A1 Novel peptide compositions and uses therefor |
| 01/26/1994 | EP0579695A1 Reissert compounds as anti-hiv agents |
| 01/26/1994 | EP0579685A1 Plasmides for the expression of filamentous haemagglutinin (fha) and hosts therefor |
| 01/26/1994 | EP0579647A1 Anti-cancer coumpounds |
| 01/26/1994 | EP0579611A1 Peptides |
| 01/26/1994 | EP0428573B1 Method and compositions for the treatment and prevention of septic shock |
| 01/25/1994 | US5281710 Dynemicin analogs: synthesis, methods of preparation and use |
| 01/25/1994 | US5281703 Process for making antimicrobial quinolonyl lactams |
| 01/25/1994 | US5281628 Pharmaceuticals |
| 01/25/1994 | US5281520 Isolated DNA molecule comprising DNA segment encoding avian or mammalian acyloxyacyl hydrolase free of other genes |
| 01/25/1994 | CA1326486C Potassium clavulanate |
| 01/25/1994 | CA1326450C Modulation of aids virus-related events by double stranded rnas (dsrnas) |
| 01/25/1994 | CA1326446C Substance or pharmaceutical or cosmetic composition inhibition or destroying at least one unicellular living creature and/or at least one virus, drug or product containing such a substance, process of manufacture of such substance, chemical compound included in such substance, and process of inhibition or destruction of at least one... |
| 01/22/1994 | CA2099818A1 Antibiotic compounds |
| 01/22/1994 | CA2099817A1 Antibiotic compounds |
| 01/22/1994 | CA2099811A1 Antibiotic compounds |
| 01/21/1994 | CA2100894A1 Aminediol protease inhibitors |
| 01/20/1994 | WO1994001573A1 Vaccines against aujeszky's disease and other animal diseases containing pseudorabies virus mutants |
| 01/20/1994 | WO1994001554A1 Polypeptides, derived from endonexin 2, having hepatitis b virus receptor activity and their use in diagnostic and pharmaceutical compositions |